Management of Pericarditis in Children.
Clinical Audit of the Management of Pericarditis in Children.
1 other identifier
observational
20
1 country
1
Brief Summary
The pericardium is a double-walled sac containing the heart and the roots of the great vessels. The pericardial sac has two layers, a serous visceral l layer (also known as epicardium when it comes into contact with the myocardium) and a fibrous parietal layer. It encloses the pericardial cavity, which contains pericardial fluid. The pericardium fixes the heart to the mediastinum, gives protection against infection and provides lubrication for the heart. Pericardial diseases may be either isolated disease or part of a systemic disease Diseases of the pericardium present clinically in one of several ways
- Acute and recurrent pericarditis
- Pericardial effusion without major hemodynamic compromise
- Cardiac tamponade with cardiac compromise
- Constrictive pericarditis
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Sep 2017
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 7, 2017
CompletedFirst Posted
Study publicly available on registry
August 17, 2017
CompletedStudy Start
First participant enrolled
September 1, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2019
CompletedAugust 17, 2017
August 1, 2017
1 year
August 7, 2017
August 15, 2017
Conditions
Outcome Measures
Primary Outcomes (1)
Echocardiographic signs
1. normal cardiac size by echocardiography (measurable by echocardiographic probe) 2. normal thickening of pericardium by echocardiography .(measurable by echocardiographic probe)
one month
Eligibility Criteria
patients who above one year of age up to 18 years diagnosed with pericarditis and/or pericardial effusions are candidates for the study.
You may qualify if:
- Children with pericarditis and/or pericardial effusion above one year of age detected clinically and by echocardiography
You may not qualify if:
- children below one year of age. - children with malignant effusion.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Assiut University
Asyut, Egypt
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- OTHER
- Target Duration
- 15 Days
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal investigator
Study Record Dates
First Submitted
August 7, 2017
First Posted
August 17, 2017
Study Start
September 1, 2017
Primary Completion
September 1, 2018
Study Completion
April 1, 2019
Last Updated
August 17, 2017
Record last verified: 2017-08